Literature DB >> 18400158

Paths of convergence: sirtuins in aging and neurodegeneration.

Li Gan1, Lennart Mucke.   

Abstract

Members of the sirtuin family of protein deacetylases support and promote longevity in diverse organisms and can extend life span when upregulated. Sirtuin pathways also modulate fundamental mechanisms in aging-related neurodegenerative diseases, including protein aggregation, stress responses, mitochondrial homeostasis, and inflammatory processes. In this minireview, we will discuss how progress in understanding the neurobiology of sirtuins is shedding light on the pathogenesis of these devastating conditions. We will also examine the potential and challenges of targeting sirtuin pathways therapeutically.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18400158     DOI: 10.1016/j.neuron.2008.03.015

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  75 in total

1.  Acetylation of tau inhibits its degradation and contributes to tauopathy.

Authors:  Sang-Won Min; Seo-Hyun Cho; Yungui Zhou; Sebastian Schroeder; Vahram Haroutunian; William W Seeley; Eric J Huang; Yong Shen; Eliezer Masliah; Chandrani Mukherjee; David Meyers; Philip A Cole; Melanie Ott; Li Gan
Journal:  Neuron       Date:  2010-09-23       Impact factor: 17.173

Review 2.  Joining the dots: from chromatin remodeling to neuronal plasticity.

Authors:  Loredana Zocchi; Paolo Sassone-Corsi
Journal:  Curr Opin Neurobiol       Date:  2010-05-12       Impact factor: 6.627

Review 3.  Ageing, neuronal connectivity and brain disorders: an unsolved ripple effect.

Authors:  Daniele Bano; Massimiliano Agostini; Gerry Melino; Pierluigi Nicotera
Journal:  Mol Neurobiol       Date:  2011-01-15       Impact factor: 5.590

Review 4.  Alzheimer mechanisms and therapeutic strategies.

Authors:  Yadong Huang; Lennart Mucke
Journal:  Cell       Date:  2012-03-16       Impact factor: 41.582

5.  SIRT1 Deacetylates Tau and Reduces Pathogenic Tau Spread in a Mouse Model of Tauopathy.

Authors:  Sang-Won Min; Peter Dongmin Sohn; Yaqiao Li; Nino Devidze; Jeffrey R Johnson; Nevan J Krogan; Eliezer Masliah; Sue-Ann Mok; Jason E Gestwicki; Li Gan
Journal:  J Neurosci       Date:  2018-03-14       Impact factor: 6.167

6.  The NAD+ synthesizing enzyme nicotinamide mononucleotide adenylyltransferase 2 (NMNAT-2) is a p53 downstream target.

Authors:  Lu-Zhe Pan; Dae-Gyun Ahn; Tanveer Sharif; Derek Clements; Shashi A Gujar; Patrick W K Lee
Journal:  Cell Cycle       Date:  2014-02-07       Impact factor: 4.534

Review 7.  The importance of NAD in multiple sclerosis.

Authors:  W Todd Penberthy; Ikuo Tsunoda
Journal:  Curr Pharm Des       Date:  2009       Impact factor: 3.116

8.  Distinct patterns of sirtuin expression during progression of Alzheimer's disease.

Authors:  Mirjam I Lutz; Ivan Milenkovic; Günther Regelsberger; Gabor G Kovacs
Journal:  Neuromolecular Med       Date:  2014-01-25       Impact factor: 3.843

Review 9.  Brain activation of SIRT1: role in neuropathology.

Authors:  Alanna Fernandes Paraíso; Keila Lopes Mendes; Sergio Henrique Sousa Santos
Journal:  Mol Neurobiol       Date:  2013-04-25       Impact factor: 5.590

10.  Potential role of sirtuin as a therapeutic target for neurodegenerative diseases.

Authors:  Seol-Heui Han
Journal:  J Clin Neurol       Date:  2009-09-30       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.